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The allotypic determinants exclusively expressed on suppressor T  cells  (Tsud) a or 
inducer of suppressor T  cells  (Tind  d)  have been demonstrated  (1,  2)  by antisera or 
monoclonal  antibodies  that  were  made  by  immunizations  of an  immunoglobulin 
heavy chain  (Igh)  allotype congenic pair of mice (i.e.,  BALB/c anti-C.AL-20).  The 
genes coding for the T  cell allotypic determinants have unambiguously been mapped 
between the Igh constant region genes (Igh-C) and the prealbumin gene (Pre-1) on the 
12th  chromosome  (3).  Furthermore,  the  determinants  seem  to  be  present  on  the 
antigen  receptor  on  suppressor  T  cells  because  the  binding  of  idiotype-specific 
suppressor  T  cells  to  the  idiotype-bearing  Ig  was  blocked  by  the  antiserum  (1). 
Therefore, these results  suggested that  T  cell  antigen  receptors can be encoded  by 
genes linked to the Igh genes. 
In  fact,  we  have  been  able  to  demonstrate  (4)  that  the  antiserum  made  by 
immunizations of BALB/c (H-2 a, Igh-1 o) mice with T cell blasts from the Igh allotype 
cogenic mice CB-20 (H-2 a, Igh-1 b) detects the allotypic determinants on the antigen- 
specific  T  cell  factors,  i.e.,  suppressor  (TsF)  or  augmenting  factor  (TaF),  which 
suppresses or augments the in vitro secondary IgG antibody response. Further evidence 
(4,  5)  has  suggested  that  the  anti-CB-20  antiserum  contains  at  least  two  distinct 
antibodies  recognizing  the  constant  region  determinants  on  the  antigen-binding 
molecules (Ct)  of the functionally different T  cell factors (i.e.,  TsF or TaF). Genetic 
analysis (5) of the determinants using the antiserum also indicated that the allotypic 
determinants on the T  cell factors are encoded by genes linked  to the Igh-1 b genes. 
These genes are distinctly located on the right side of the Igh variable-region (Igh-V) 
genes on the  12th  chromosome because the anti-CB-20 column specifically reacted 
with T  cell factors from BAB-14 mice that carry the Igh-V genes from Igh-1 a mice and 
the Igh-C genes from Igh-1 b mice. 
Based on  the  above evidence, we tried  to establish  hybridoma-producing mono- 
clonal antibodies recognizing the Ct determinants of the antigen-specific T  cell factors 
(T cell-receptor molecules) expressed on the functionally distinct T  cell subsets. Such 
monoclonal antibodies would be useful for characterizing the biochemical properties 
of the  antigen-recognition  units  on  T  cell  subsets.  In  this  report,  we  describe  the 
1  Abbreviations used in this paper:  BPV, Bordetella  pertussis vaccine; C, complement; Con A, concanavalin 
A; Ct, constant region of the antigen-binding chain of T cell factors; DNP, 2,4-dinitrophenyl; FCS, fetal 
calf serum; HAT, hypoxanthine, aminopterin, and thymidine; KLH, keyhole limpet hemocyanin; OVA, 
ovalbumin; PBS, phosphate-buffered saline; PEG, polyethylene glycol; P3U1, P3-X63Ag8-U1; PFC, 
plaque-forming cells; SRBC, sheep erythrocytes; T, thymus derived; TaF, augmenting T cell factor; TsF, 
suppressor T cell factor. 
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establishment of three characteristic monoclonal anti-CB-20 antibodies, each of which 
reacts with the distinct constant- region determinants on the antigen-binding chain of 
TsF  or  TaF.  By  using  these  monoclonal  antibodies,  some  functional  and  genetic 
properties of the T  cell factors will also be described. 
Materials and  Methods 
Animals.  C57BL/6 CrSlc (H-2 b, Igh-I o), BALB/c CrSlc (H-2 a, Igh-I a) mice were purchased 
from Shizuoka Experimental Animal Laboratory, Co. Ltd., Hamamatsu, Japan. Igh allotype 
congenic  mice,  CB-20  (H-2 a,  Igh-lb),  BAB-14  (H-2 a,  Igh-lb),  C3H.SW/Hz  (CSW;  H-2 b, 
Igh-lY), and CWB/Hz (H-2 b, Igh-1 b), have been maintained in our animal facility. 
Antigens.  Keyhole limpet hemocyanin  (KLH)  was  purchased  from  Calbiochem Behring 
Corp., American Hoechst Corp., San Diego, CA. Ovalbumin (OVA), recrystallized five times, 
was obtained from  Sigma Chemical Co.,  St Louis, MO.  Dinitrophenylated KLH  (DNP770- 
KLH), and OVA (DNPs-OVA) were prepared by coupling with 2,4-dinitrobenzensulfonic acid 
under alkaline conditions. Bordetella  pertussis vaccine (BPV) was obtained from the Chiba Serum 
Institute, Chiba, Japan. 
Antiserum.  Anti-I-J  b, B10.A(5R) anti-B10.A(3R) was raised in our laboratory by the recip- 
rocal immunization of the spleen and thymus cells. (A/J ×  B 10.MBR)Fa anti-B 10.A(5R) (anti- 
I-AbB  b) was kindly provided by Dr. D. H. Sachs, National Cancer Institute, National Institutes 
of Health, Bethesda, MD. 
Immunization.  Immunization protocol to produce antibodies specific for T  cell factors was 
described previously (4). Briefly, BALB/c mice were immunized intravenously with 107 CB-20 
spleen cells preeultivated with 5 #g/ml of concanavalin A (Con A; Sigma Chemical Co.) for 48 
h. The animals were immunized more than  10 times at weekly intervals. 
Cell Fusion and Cloning.  3 d after the last immunization, cell hybridization was carried out 
by the method described elsewhere (6). In brief, l0  s primed spleen cells were mixed with  10  7 
P3-X63Ag8-U 1 (P3U1) in a 50-ml tube and pelleted by centrifugation at 400 g. The cells were 
then resuspended in  1 ml prewarmed (37°C)  50%  polyethylene glycol (PEG;  1,500  mol wt; 
Sigma Chemical Co.) by gentle shaking, followed by the dropwise addition of 1 ml of serum- 
free RPMI  1640 (GIBCO Laboratories, Grand Island Biochemical Co., Grand Island, NY). 
The cells were further diluted with RPMI  1640 and then centrifuged at 200 g for 5 min. The 
cell pellet was resuspended with warm medium containing 1 ×  10-  M hypoxanthine, 4 ×  10  -7 
M  aminopterin,  and  1.6  ×  10  -5  M  thymidine  (HAT).  100  /L1  of the  cell suspensions was 
distributed to each well of a 96-well tissue culture plate (3042;  Falcon Labware, Div. of Becton, 
Dickinson & Co., Oxnard, CA). Hybrids were cultured in HAT medium for 2-4 wk. Culture 
supernatants were added to the spleen cell culture to detect the antibody activity, as described 
below. Cells in the positive wells were cloned at least twice with limiting dilution. 
Cytotoxic Test.  The two-step cytotoxic assay was performed as described elsewhere (6).  105 
suppressor T cell hybridoma (34S-704)  cells were incubated with 20 pl of diluted antiserum for 
30 min at 4°C. After washing once, the cells were treated with 20 btl of rabbit complement (C) 
for 30 min at 37°C.  200 cells were counted per well under the light microscope by a  trypan 
blue dye exclusion. 
Quantitative Absorption of the  Monoclonal Anti-CB-20  (7C5)  with  Spleen Cells.  Quantitative 
absorption studies were carried out in a V-bottomed microtiter plate (Dynatech Laboratories, 
Inc., Dynatech Corp., Alexandria, VA). 30 pl of a  1:2,000  diluted culture supernatant from a 
hybridoma line (7C5)  that showed the end point of maximum cytotoxicity was absorbed with 
graded numbers (3-192 ×  106 cells/ml ×  30 #1) of spleen cells from various strains of mice for 
1 h at 4°C. The supernatants were collected by centrifugation and then tested for the cytotoxic 
activities on the antigen-binding  +, I-J  + suppressor T  cell hybridoma cells (34S-704). 
Preparation of the Antigen-specific Suppressor (TsF) and Augmenting T  Cell Factor (TaF).  The 
method used to obtain TsF and TaF was described in detail elsewhere (7). Briefly, mice were 
immunized intraperitoneally twice with 200/zg of KLH or OVA at a 2-wk interval. 2 wk after 
the last immunization, spleen cells were obtained and subsequently disrupted by freezing and 
thawing. The cell-free extracts were obtained by ultracentrifugation at 40,000 g for 1 h. 
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containing TsF and TaF was applied to immunoadsorbent columns composed of monoclonal 
antibodies and incubated for 1 h at 4°C. Effluent was collected by passing through the columns. 
After extensive washing with RPMI  1640  medium, the materials were then eluted from the 
columns with 2 ml of 0.175 M  glycine-HC1 buffer, pH 3.2, at 4°C. The eluates were instantly 
neutralized with 0.4 M sodium bicarbonate and dialyzed with phosphate-buffered  saline (PBS), 
pH 7.2. They were then concentrated by vacuum pressure. 
In  Vitro Culture System.  Modified Mishell-Dutton culture system using a  96-well microtiter 
plate (Falcon 3042)  was used. 8  5  ....  ×  10  spleen cells from mine primed 6 wk previously wxth  100 
~g of DNP-KLH or DNP-OVA and  10~BPV were cultured in 0.2 ml of RPMI  1640  enriched 
with  10%  fetal calf serum in the presence of 0.1  #g/ml of DNP-KLH or DNP-OVA and 2  × 
10  -5 M  2-mercaptoethanol at 37°C in 5% CO2 in air for 5 d.  10 btl of cell-free extract equivalent 
to 2 X  106 spleen cells was added to the culture on day 0, to examine the TsF activity, or on day 
2, for testing the TaF activity. 5 d later, numbers of anti-DNP IgG plaque-forming cells (PFC) 
were assayed by using DNP-coupled erythrocytes. 
Statistical Analysis.  For in vitro PFC assays, results were analyzed with a two-tailed Student's 
t test. Probability values of > 10% were considered to be insignificant. 
Results 
Screening  of  the  Monoclonal Anti-CB-20  Antibodies  Specific for  Functional  T  Cell 
Factors.  Our previous studies  (4)  have shown that  immunizations of BALB/c mice 
with Igh allotype-congenic spleen cells (CB-20) successfully produced antisera specific 
for the allotypic determinants of T  cell factors  (TsF or TaF). Therefore, BALB/e- 
derived myeloma cells  (P3U1)  were hybridized with  spleen cells of BALB/c mice 
hyperimmunized with CB-20 spleen cells. To select hybridoma-producing antibodies 
specific for TsF or TaF, DNP-KLH-primed spleen cells were cultivated with hybrid- 
oma culture supernatant in the presence or absence of the KLH-specific T cell factors. 
As shown in Table I, culture supernatants of the 7C5, 7D1, or 6A4 clone did not show 
TABLE  I 
Inhibitory Effects of Monoclonal BALB/c Anti-CB-20 Antibodies  on the Activity of TsF or TaF 
IgG anti-DNP PFC/culture* 
Monoclonat  Experiment l  Experiment 2 
antibodies~  Materials added§  Materials addedll 
added  on day 0  on day 2 
Medium  TsF  Medium  TaF  P value¶ 
Medium  3,100 + 620**  440 ±  300  1,270 ±  220  2,050 ±  220  <0.001 
7C5  2,820 ±  550  2,300 :tz 260  ND:~  ND  -- 
7D1  2,940 +  700  2,490 +-- 390  ND  ND  -- 
6A4  ND  ND  1,030 ±  200  1,230 ±  260  NS§§ 
* 8  ×  105  DNP-KLH-primed spleen  cells from  C57BL/6  mice  were  cultured  in  0.2  ml  of a  96-well 
microtiter plate in the presence of hybridoma supernatants and antigen-specific  T cell factors. 
:~ 50/~1 of hybridoma supernatant or medium was added to the in vitro secondary anti-DNP IgG response 
of spleen cells of C57BL/6 mice at the start of cultivation. 
§ The cell-free extract equivalent to 2 ×  106 spleen cells of KLH-primed C57BL/6 mice was added to the 
culture on day 0 to detect the TsF activity. 
II The cell-free extract equivalent to 2 ×  106 spleen cells of KLH-primed C57BL/6 mice was added to the 
culture on day 2 to detect the TaF activity. 
¶ Significance level of difference from the spleen cell culture without TaF (control). 
**  Results are expressed as arithmetic mean numbers of anti-DNP IgG PFC of six cultures  +  SD. 
~:~ Not done. 
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any effect on the in vitro secondary antibody response when they were cultured with 
spleen cells in the absence of the T  cell factors. However, the hybridoma supernatants 
abrogated the KLH-TsF or KLH-TaF activity in the presence of T  cell factors. These 
results suggest that  the hybridoma antibodies specifically reacted with TsF or TaF 
and resulted in eliminating the activities of the T  cell factors. The isotype of the 7C5, 
7D1, or 6A4 antibody was found to be IgM, IgM, IgG1, respectively, as determined 
by radioimmunoassay described elsewhere (8). 
Monoclonal Anti-CB-20  (7C5,  6A4,  and  7D1)  Antibodies  Recognizing  Constant  Region 
Determinants on Antigen-specific  T  Cell Factors.  To examine the determinants of T  cell 
factors recognized by monoclonal anti-CB-20 antibodies, the KLH- or OVA-specific 
T  cell factors were absorbed with immunoadsorbent columns of the 7C5, 6A4, or 7D 1 
antibody. The materials were also eluted from the columns with 0.175 M  glycine-HC1 
buffer, pH 3.2.  The effluent or the eluate was added to the culture of DNP-KLH- or 
DNP-OVA-primed spleen cells on day 0, to detect the suppressor (TsF) activity, and 
also added on day 2, to determine the augmenting (TaF) activity. The data shown in 
Table II demonstrated that the 7C5 column absorbed the KLH-TsF and OVA-TsF 
but not TaF. On the contrary, the 6A4 reacted only with TaF. These results indicate 
that the 7C5 and 6A4 antibodies recognize the distinct constant region determinants 
exclusively  expressed  on  the  TsF  and  TaF,  respectively.  The  7D1  antibody  was, 
however, shown to be directed to the constant region determinants shared in TsF and 
TaF because the 7D1 column absorbed both TsF and TaF. 
Genetic Specificity of Monoclonal Anti-CB-20  (7C5,  6A4,and 7DI)  Antibodies.  Genetic 
specificities of the monoclonal anti-CB-20 antibodies were examined by absorption of 
KLH-TsF and  KLH-TaF with  immunoadsorbent  columns  composed  of the  7C5, 
6A4, or 7D1  antibody. The effluent or the eluate from these columns was added to 
the culture on day 0 and on day 2. As TsF or TaF has been demonstrated to suppress 
or enhance  the  in  vitro secondary IgG responses of the I-J-  or the/-A-compatible 
strains of mice (7, 9), respectively, the activities of KLH-TsF and KLH-TaF obtained 
from C57BL/6, C3H.SW, and CWB mice having the I-J b and LA b haplotypes were 
tested in the responses of DNP-KLH-primed C57BL/6 (H-2 b) spleen cells. Similarly, 
KLH-TsF  and  KLH-TaF from I-J a  and  I-A a  (BALB/c  and  BAB-14)  mice  were 
added  to the cultures  of DNP-KLH-primed BALB/c  (H-2 a)  spleen cells. Table III 
shows that the monoclonal antibody columns successfully absorbed the KLH-specific 
T  cell factors from the Igh-1 b (C57BL/6, CWB, and BAB-14) mice but not those from 
BALB/c (Igh-1 a) and C3H.SW (Igh-1))  mice. The results indicate that the 7C5, 6A4, 
and  7D1  antibodies recognize the allotypic determinants on TsF and TaF from the 
Igh-1 b mice. 
The  genetic  specificity  of  the  7C5  antibody  (IgM)  specific  for  TsF  was  also 
investigated by a  cytotoxic inhibition  assay. The diluted culture supernatant  of the 
7C5  clone that  showed  an end  point  of maximum cytotoxic activity was  absorbed 
with  graded  numbers  of spleen  cells  from  various  strains  of mice.  The  residual 
cytotoxic activity was tested on the suppressor T  cell  hybridoma.  Fig.  1 shows  the 
cytotoxic curves of the 7C5 antibody after absorption with spleen cells from C57BL/ 
6 (Igh-lb),  BALB/c (Igh-la),  BAB-14 (Igh-lb),  C3H.SW (Igh-lJ),  and CWB (Igh-1 b) 
mice. The cytotoxic activity of the  7C5  was absorbed with spleen cells from Igh-1 b 
mice,  such  as  C57BL/6,  BAB-14,  and  CWB  mice,  but  not  those  from 
BALB/c and C3H.SW mice with different Igh allotypes. It is, therefore, clear that the 892  MONOCLONAL ANTI-T  CELL  RECEPTOR 
TABLE II 
Monoclonal BALB/c Anti-CB-20 Antibodies React with Constant Region Determinants of Antigen-specific 
T Cell Factors 
C57BL/6 factor*  IgG anti-DNP PFC/culture 
Specific  Absorbed  Materials added:l: 
for  with  TsF§  TaFII  P value¶ 
--  --  --  1,430 ±  230**  1,090 ±  160  -- 
KLH  --  Unabsorbed factor  160  ±  80  2,090 ±  270  <0.001 
KLH  7C5  Effluent  1,500 +  100  2,100 +  270  <0.001 
KLH  7C5  Eluate  180  +  90  1,000 ±  370  NS~:~ 
KLH  6A4  Effluent  220  ±  80  1,210 ±  130  NS 
KLH  6A4  Eluate  1,440 ±  340  2,630 +  260  <0.00t 
KLH  7D1  Effluent  1,420 ±  240  1,070 ±  140  NS 
KLH  7D1  Eluate  230  ±  100  2,500 ±  460  <0.001 
--  --  --  1,010 ±  130  1,610 +-- 270  -- 
OVA  --  Unabsorbed factor  130  +  50  3,330 +  330  <0.001 
OVA  7C5  Effluent  1,200 ±  160  3,070 +  270  <0.001 
OVA  7C5  Eluate  60  ±  20  1,480 +  220  NS 
OVA  6A4  Effluent  150  ±  100  1,280 ±  260  NS 
OVA  6A4  Eluate  1,050 ±  200  2,900 +  260  <0.001 
OVA  7D1  Effluent  1,110 ±  200  1,610 ±  200  NS 
OVA  7D1  Eluate  120  ±  100  3,720 ±  590  <0.001 
* The cell-free extract equivalent to 2 ×  106 spleen cells of KLH- or OVA-primed C57BL/6 mice was 
absorbed with and eluted from immunoadsorbent columns of monoclonal antibodies. 
:~ The effluent or the eluate from the columns was added to the culture on day 0 (TsF) or on day 2 (TaF) 
to detect the TsF or TaF activity. 
§ The KLH-specific or OVA-specific spleen cell extract from C57BL/6 mice was added on day 0 to the 
culture  of DNP-KLH-  (upper  column)  or  DNP-OVA-  (lower  column)  primed  spleen  ceils  from 
C57BL/6 mice, respectively. 
11 The KLH-specific or OVA-specific spleen cell extract from C57BL/6 mice was added on day 2 to the 
culture  of DNP-KLH-  (upper  column)  or  DNP-OVA-  (lower  column)  primed  spleen  ceils  from 
C57BL/6 mice, respectively. 
¶ Significance level of difference from the spleen cell culture without TaF (control). 
** Results are expressed as arithmetic mean numbers of anti-DNP IgG PFC of six cultures +  SD. 
:~k Not significant. 
7C5  antibody recognizes T  cell surface products encoded by Igh-lb-linked  genes. 
Allotypic  Determinants  Are  Present on  Antigen-binding  Chains  of T  Cell Factors.  It  has 
been demonstrated (10,  11)  that KLH-TsF  is composed of two discrete molecules, i.e., 
the  KLH-binding  and  the  I-J-bearing  chains  in  noncovalent  association  in  the 
extracted TsF, and that these two chains, neither of which could exert any function 
by itself, reconstituted the TsF activity when mixed together. Therefore, the extracted 
KLH-TsF  was absorbed with immunoadsorbent  columns composed of KLH,  7C5, or 
anti-I-J  b  to  determine  whether  the  7C5  reacts  with  the  KLH-binding  or  the  I-J- 
encoded molecule. The effluents, or a  mixture of these from any two of the columns, 
were added to the culture on day 0. The results shown in Table IV demonstrated that 
the TsF  activity  was completely absorbed with  any  of the columns.  No  suppressor 
activity was detected in the effluent from the columns. However, the mixture of the 
effluents from the KLH  and  anti-I-J  b or from the  7C5  and  anti-I-J  b,  but  not  those 
from the KLH  and 7C5 columns, reconstituted the strong suppressor activities. From 
our  previous experiments, together with the results shown in Table  IV,  the effluent T.  TOKUHISA,  Y.  KOMATSU,  Y.  UCHIDA,  AND  M.  TANIGUCHI 
TABLE  III 
Genetic Specificity  of Monoclonal BALB/c  Anti-CB-20  Antibodies 
893 
IgG anti-DNP  PFC/culture* 
Faeto~ ab-  Materials added  Added§  Factors derived from 
sorbed with  on day 
C57BL/6  C3H.SW  CWB  BALB/c  BAB-14 
--  --  --  1,610 4. 23011  1,980 4. 240  4,220 4. 730  2,350 4- 80  1,720 4- 140 
--  Unabsorbed factor  0  190 ± 90  180 ±  110  1,290 4. 240  140 4. 120  170 4. 150 
7C5  Effluent  0  1,360 4, 210  100 ± 80  3,910 4. 610  240 ±  70  2,100 4. 130 
7C5  Eluate  0  150 4. 60  1,970 4. 300  1,430 ± 480  2,260 :t= 180  140 4. 50 
7DI  Effluent  0  1,580 4. 110  100 4. 60  3,780 ±  120  230 4. 140  1,900 4. 220 
7D1  Eluate  0  140 4. 60  1,920 4. 190  1,360 3:200  2,360 4. 360  150 4. 80 
--  --  --  1,3704,  190  1,0104.  180  1,1404-  180  1,0204,  70  1,750±210 
--  Unabsorbed factor  2  2,910 + 390¶  2,260 -4- 330¶  2,280 4, 310¶  2,480 ±  190~  3,630 4- 620¶ 
6A4  Effluent  2  1,210 4- 130"*  2,370 +  160¶  1,125:1:  260**  2,730 4. 380~  2,100 ± 360** 
6A4  Eluate  2  2,630 "4- 260¶  1,010 4. 160"*  2,1)80 ±  180¶  1,110 4. 120"*  3,740 ± 570¶ 
7DI  Effluent  2  1,260 ± 60**  2,180 4. 380¶  1,040 ± 50**  2,800 4. 430¶  1,730 4. 330** 
7D1  Eluate  2  2,860 ± 360¶  1,120 4- 140"*  2,170 4. 320¶  1,160 4. 170"*  3,560 4. 100¶ 
* The KLH-TsF derived from C57BL/6 (H-2  b, Igh-16), C3H.SW (H-2  b, Igh-l)), and CWB (H-2  b, Igh-I  b) mice was added to the culture of 
DNP-KLH-primed C57BL/6 mice. The KLH-TsF from BALB/c (H-2  a, Igh-I  a) and BAB-14 (H-2  a, Igh-l  b  ) mice was added to the culture 
of DNP-KLH-primed  BALB/c mice. 
:~ The cell-free extract  equivalent  to 2 ×  10  n spleen cells of KLH-primed  mice was absorbed with  the columns composed of monoclonal 
antibodies. See Table  II. 
§ See Table 1I. 
[[ Results are expressed as arithmetic mean numbers of anti-DNP  IgG PFC of six cultures 3= SD. 
¶ Significance level of difference from the spleen cell cuture without TaF; P < 0.001. 
** Significance level of difference from the spleen cell culture without TaF;  P > 0.1 (NS). 
3  12  48  192  xlOI  AN 
Numbers of spleen cells obsoflx~ 
Fro.  1.  Quantitative  absorption  analysis of the  monoclonal  BALB/c  anti-CB-20 antibody  (7C5) 
specific for TsF. 30/,tl of 1:2,000 diluted culture supernatant  from the 7C5 clone was absorbed with 
graded  numbers  (3-192  ×  108  cells/ml  ×  30 pl)  of the  following spleen  cells:  C57BL/6  (Igh-I b) 
(×), C3H.SW  (Igh-I j)  (A), CWB  (Igh-I b)  (A), BALB/c  (Igh-I a) (11), and BAB-14 (Igh-1 b) ([]).  The 
residual eytotoxic activities were assayed on the KLH-specific suppressor T  cell hybridoma  (Mate- 
rials and  Methods). The  background  killing  was <  10%. 
from the anti-I-j  b column should contain the KLH-binding molecule. Similarly, the 
KLH column  supplies  the  I-J molecules in  the  effluent.  Because  the  7C5  column 
behaves  the  same as  the  KLH column  in  Table  IV,  it  is  likely that  7C5  has  the 
capacity to absorb the KLH-binding molecules but not the I-J molecules. 
As TaF has been demonstrated to have the antigen-binding  moiety and the I-A- 894  MONOCLONAL  ANTI-T  CELL  RECEPTOR 
TABLE  IV 
Monoclonal 7C5 and 6A4 Antibodies Recognizing Antigen-binding Chains of Antigen-specific T Cell 
Factors 
C57BL/6  factor absorbed with* 
None  KLH  Anti-I-J  b  7C5  Anti-I-A  b  6A4 
IgG anti-DNP  PFC/culture:~ 
Materials added  on 
P 
Day 0  Day  2  value§ 
......  1,740 +  42011  1,160 ±  160  -- 
2  ×  106¶  .....  220 :l:  170  2,170 ±  400  <0.001 
--  4  ×  106  ....  1,420 +  130  1,180 ±  220  NS** 
--  --  4  x  106  --  --  --  1,700 ±  410  ND~:~ 
--  --  --  4  X  106  --  --  1,630 ±  620  ND 
....  4  ×  106  --  ND  960 ±  90  >0.05 
.....  4  x  10  ~  ND  1,170 :!:  260  NS 
--  2  x  106  2  x  106  --  --  --  340 ±  180  ND 
--  2  X  106  --  2  ×  106  --  --  1,380 +  240  ND 
--  --  2X  106  2X  106  --  --  260±  110  ND 
--  2  X  106  --  --  2  X  106  --  ND  2,150 ±  330  <0.001 
--  2  ×  106  --  --  --  2  X  10  6  ND  1,170 ±  170  NS 
....  2  x  10  s  2  x  106  ND  2,290 ±  200  <0.001 
* The  cell-free extract equivalent to 8  X  108 spleen cells from KLH-primed  C57BL/6  mice was adsorbed 
with immunoadsorbent  columns. 
:~ The  effluent  or the  mixture  of the one-half volume  of effluents  from  these columns  was added  to  the 
DNP-KLH-primed  C57BL/6  spleen cell culture on day 0  or on day 2. 
§  Significance level of difference from the spleen cell culture without TaF  (control). 
[I Results are expressed as mean  numbers  of anti-DNP  IgG PFC  of six cultures  ±  SD. 
¶  Cell numbers  equivalent to the amount  of absorbed  factors added  to the culture. 
** Not significant. 
:H: Not done. 
subregion  gene products,  the  experiment was designed  to examine whether TaF  is 
composed of two chains  like TsF  and  whether  the  determinant  defined  by 6A4  is 
present on the antigen-binding molecule. For this, a  similar experiment described in 
the  previous section  using  the  anti-I-A  b and  6A4 columns was carried  out.  In  this 
experiment, the extracted T  cell factor was added to the culture on day 2. The results 
in Table IV show that the augmenting activity was reconstituted by the mixture of 
the effluents from the  KLH and anti-LA  b or from the 6A4 and  anti-I-A  b columns, 
neither of which showed any TaF activity by itself. The results indicate that TaF is 
also composed of two chains and that the 6A4 antibody reacted the molecules with 
antigen-binding moiety of TaF. It is, therefore, concluded that 7C5 and 6A4 recognize 
the determinants expressed on the antigen-binding molecules of the functional subsets 
of T  cells. 
Discussion 
The hybridomas producing antibodies specific for allotypic markers on the antigen- 
binding molecules of functional T  cell factors have been established by the fusion of 
BALB/c myeloma (P3U1)  and  BALB/c spleen  cells hyperimmunized with Con A- 
stimulated spleen cells of Igh allotype congenic mice  (CB-20).  The antibodies were 
successfully selected  by functional  assays  as  shown  in  Table  I.  The  7C5  and  7D1 
antibodies  (IgM) were seen to have the ability to block the TsF activity when they T. TOKUHISA, Y.  KOMATSU, Y.  UCHIDA, AND M.  TANIGUCHI  895 
were  added  together  with  TsF  into  the  in  vitro  secondary  antibody  responses. 
Similarly, the addition of the 6A4 antibody (IgG1) to the culture resulted in abrogating 
the TaF activity. 
The reactivity of monoclonal antibodies was further investigated. It is demonstrated 
in Table III that the antibodies absorb suppressor or augmenting T  cell factors from 
Igh-1 b mice (i.e., C57BL/6, BAB-14, and CWB) but not those from mice with different 
Igh allotypes, such as BALB/c  (Igh-I b)  and C3H.SW  (Igh-1 j)  mice. Therefore, the 
monoclonal  antibodies  seem  to  recognize  the  allotypic  determinants  on  antigen- 
specific T  cell factors from Igh-1 b mice. Furthermore, radioimmunoassay using 125I- 
labeled 7C5, 6A4, and 7D1  antibodies excluded the possibility that they might react 
with  allotypic determinants  of the Igh-1 n Ig or C57BL/6  splenic  B  cells  (data  not 
shown). Thus, the determinants appear to be different from the allotype markers of 
Ig and B cells. Genetic specificities of the 7C5 and 7D1 antibodies were also confirmed 
by  quantitative  absorption  with  spleen  cells  from  various  strains  of mice.  It  can, 
therefore, be strongly suggested that the monoclonal alloantibodies described here are 
specific for the allotype markers on T  cells and their factors encoded by genes linked 
to the Igh-1 b gene cluster. Fig.  1 also shows that the capacity of C57BL/6 spleen cells 
to absorb the 7C5 antibody activity was about five times more efficient than that of 
the spleen cells from other Igh-1 b mice. No explanation for this can be offered at this 
time.  It  is,  however,  possible  that  this  might  be  because  of the  difference  in  the 
number of 7C5 positive cells among the various mouse strains. 
The antigen-specific suppressor T  cell  factor has been  demonstrated  to bear the 
antigen-binding  structure  as  well  as  the  constant  region  determinants  that  were 
defined by the xenoantiserum  against  mouse suppressor T  cell  factors  (rabbit anti- 
mouse TsF) (12). No genetic analysis of constant determinants on TsF was performed. 
However, recent studies reported by Owen et al. (1) and Tokuhisa and Taniguchi (4) 
have strongly suggested that T  cell allotypic determinants encoded by genes linked to 
the  Igh  locus  are  expressed  on  T  cell  antigen  receptors  or  antigen-specific  T  cell 
factors. In this respect, the monoclonal antibodies (7C5, 7D1, and 6A4) were found to 
recognize constant region determinants on antigen-binding molecules of T  cell factors 
(Tables II and IV) because the monoclonal antibody has the ability to absorb both 
KLH- and OVA-specific T cell factors, both of which should have the distinct variable 
region  structure.  However, our results  in  Tables  II and  IV could  not  exclude  the 
possibility that  the antibody might react with  variable region  determinants  in case 
there might be allotypic markers in the variable region of the T  cell receptor similar 
to the allotypes of the rabbit Ig (13). 
It  is  clear  that  the  monoclonal  6A4  and  7C5  antibodies  recognize  the  distinct 
antigen-binding  molecule on different  functional  T  cell  factors  (Tables II and  IV). 
However, the 7D1 antibody recognizes the shared constant determinants between TsF 
and TaF (Table II). Therefore, at least two discrete genes coding for the Ct of T  cell 
receptors can be supposed to be present on the 12th chromosome. Genetic specificities 
of the monoclonal antibodies have further shown that both genes coding for the Ct 
molecules locate to the right side of the Igh-V genes on the 12th chromosome because 
the antibodies absorb T  cell factors from Igh-1 b mice and BAB-14 mice carrying the 
Igh-C  genes  from Igh-1 b mice  and  the  Igh-V  genes  from  Igh-1 '~  mice  (14).  In  this 
respect, the existence of a  gene complex, downstream  from Igh-1  and  coding  for a 
family of T  cell isotypes (Tsu  d, Tind  d, or Tthyd), has been proposed by Owen et al. 896  MONOCLONAL ANTI-T CELL RECEPTOR 
(15).  We cannot determine at this time whether or not the Ct determinants defined 
by our  monoclonal  reagents  are  identical  to  Tsu  d and  Tind  d.  In  any  event,  it  is 
possible  that  the  cluster  of genes  coding  for  the  constant  region  determinants  of 
antigen-receptors on functionally different T  cell subsets locates adjacent to the Igh-C 
genes on the  12th chromosome. 
We previously reported the existence of the antigen-specific T  cell factor (TaF) that 
augments  antibody  responses  (7).  "This  factor  was  shown  to  possess  an  I  region 
determinant encoded by an unique gene in the I-A subregion that is not identical to 
that coding for the B cell Ia antigen (7,  16). The results in Table IV demonstrate that 
TaF is composed of two distinct  chains,  one possessing the antigen-binding  moiety 
and the other the product of a gene in the I-A subregion and that the 6A4 antibody 
reacts with the molecules having the KLH-binding moiety. Therefore, the antigen- 
specific TaF has a  structural  resemblance to the antigen-specific TsF (10).  TaF was 
also found to have similar characteristics to TsF in that the mixture of the two chains, 
neither  of which  could  exert  any  functional  activity  by  itself,  could  successfully 
reconstitute the augmenting activity. 
From our previous studies on the hybridoma-derived TsF  (10,  11),  together with 
the  data  presented  here,  it  is  strongly suggested  that  I  region  gene products being 
associated with the antigen-binding chain of T  cell factors act as elements to convey 
T  cell functions (i.e., suppressing or augmenting). As antigen-binding chains have the 
Ct determinants unique  to functionally different T  cell subsets, it is also likely that 
the  Ct molecules serve as  functional  domains  of T  cell  factors similarly to  the  Fc 
domain of Ig. In this regard, it is imperative to conduct investigations of the biological 
roles of the  molecules responsible  for the  expression  of the  functions  of the  T  cell 
factors.  Further  studies  using  monoclonal  antibodies  (7C5  and  6A4),  currently  in 
progress, are awaiting results to answer these questions. 
Summary 
We  established  three  distinct  monoclonal  antibodies  (7C5,  7D1;  IgM  and  6A4; 
IgG1) by the fusion of P3U1  and BALB/c (Igh-I a) spleen cells hyperimmunized with 
T  cell blasts from the immunoglobulin heavy chain  (Igh)  allotype congenic CB-20 
(Igh-I b) mice. The 7C5 or 6A4 antibody reacts with the constant region determinants 
on the antigen-binding molecule (Ct)  of the antigen-specific suppressor T  cell factor 
(TsF)  or augmenting T  cell factor (TaF), respectively. The 7D1  antibody, however, 
recognizes the  shared  determinants  on  the  Ct  molecules of TsF  and  TaF.  Genetic 
studies of determinants recognized by these monoclonal antibodies have also suggested 
that  the  distinct  Ct molecules of TsF and TaF  are encoded  by two  discrete  genes 
linked to the Igh-1 b genes, which are located on the right side of the variable genes of 
Igh  on  the  12th  chromosome.  By  using  the  immunoadsorbent  columns  of 6A4 
antibody and  anti-I-A  b, TaF, in a  manner similar to TsF, was demonstrated  to be 
composed of two chains,  i.e.,  the Ct molecules and  the I-A-encoded products.  Fur- 
thermore, the Ct-bearing molecules were shown to possess the antigen-binding moiety. 
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